Phase II Trial of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Adenocarcinoma of the Prostate.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Paclitaxel (Primary) ; Bicalutamide; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Jan 2009 Planned patient numbers amended from 40 to 14 as reported by ClinicalTrials.gov.
- 30 Jan 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.